
CLIFF
Healthcare · Diagnostics & Research · $32.9M market cap
$0.12830.00 (0.0%)Nov 13, 9:30 AM EST
Latest report
Time not confirmed
The next earnings date isn’t on the calendar yet.
Analyst consensus
Fiscal period ending Sep 30, 2016
EPS trend, 90 days to now · 30-day revisions 0 up, 0 down
Beat estimates in 0 of the last 4 reported quarters.
EPS surprise versus the estimate at the time of the report.
| Date | Session | Estimate | Actual | Surprise |
|---|---|---|---|---|
| Jun 30, 2021 | Time not confirmed | 0.00 | 0.00 | — |
| Mar 31, 2021 | Time not confirmed | 0.00 | 0.00 | — |
| Dec 31, 2020 | Time not confirmed | 0.00 | 0.01 | — |
| Sep 30, 2020 | Time not confirmed | 0.00 | 0.01 | — |
| Apr 15, 2020 | Before the open | 0.00 | 0.00 | — |
| Mar 31, 2020 | Time not confirmed | — | 0.00 | — |
| Nov 13, 2019 | Before the open | — | 0.01 | — |
| Sep 30, 2019 | Time not confirmed | — | 0.00 | — |
| Jun 30, 2019 | Time not confirmed | — | 0.00 | — |
| Mar 31, 2019 | Time not confirmed | — | 0.00 | — |
| Dec 31, 2018 | Time not confirmed | — | -0.00 | — |
| Aug 14, 2018 | Before the open | — | 0.00 | — |
| May 11, 2018 | Time not confirmed | — | 0.00 | — |
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. It operates in two segments, Banking and Diagnostics. The Banking segment collects, processes, banks, and tests biological materials, such as cord blood, lining, and tissue samples. The Diagnostics segment offers diagnostic testing services, such…
| After the close |
| — |
| 0.00 |
| — |